Andreessen Horowitz's Life Science Portfolio

BigHat Biosciences develops antibody and protein therapeutics using machine learning, synthetic biology, and automated experimentation.

Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR molecules.

Erasca is a developer of oncology drugs intended to provide precision oncology options.

Cartography is an oncology company that develops cancer immunotherapies that target novel and highly specific tumor antigens.

Phylo provides an integrated workspace with AI-assisted tools to support planning, execution, and review of biological research.

Nautilus Biotechnology is a life sciences company that develops a platform for analyzing and quantifying the human proteome.

BioAge Labs is a clinical-stage biotechnology company that develops therapeutics to treat obesity and metabolic diseases.

Gate Bioscience is a biotechnology company that specializes in a small molecule modality to treat biology’s intractable diseases.

Braveheart Bio is a clinical-stage biotechnology company focused on developing precision therapies in the cardiovascular disease space.

Deepcell is a life science company specializing in AI-powered single-cell classification and isolation for basic and translational research.

GC Therapeutics uses synthetic biology to program patient-derived stem cells into various cell types in an efficient and scalable manner.

Idrx is a clinical-stage biopharmaceutical that develops oncology-based precision therapies to treat cancer.

Elegen is a biotechnology company that develops microfluidic technology.

Inceptive designs RNA molecules using large-scale deep learning in a tight loop with high-throughput experiments.

Orbital Therapeutics is a biotechnology company that develops RNA-based medicines to treat disease in humans.